These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7879017)

  • 1. Use of gene therapy to induce antigen-specific immunologic unresponsiveness to class I xenogeneic major histocompatibility complex antigens.
    Schumacher I; Jeevarathnam S; Rubbocki R; Fox IJ
    Transplant Proc; 1995 Feb; 27(1):313-4. PubMed ID: 7879017
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of gene therapy to induce human-mouse xenogeneic chimerism.
    Fox IJ; Athan E; Fisher J; Baxter T; Podda S; Richardson C
    Surgery; 1993 Aug; 114(2):174-81; discussion 181-2. PubMed ID: 8342123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen.
    Schumacher IK; Newberg MH; Jackson JD; Hammel JM; Rubocki RJ; Engelhard VH; Fox IJ
    Transplantation; 1996 Sep; 62(6):831-6. PubMed ID: 8824485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral vectors for long-term expression of allogeneic major histocompatibility complex transduced into syngeneic bone marrow cells.
    Hayashi H; Lee RS; Germana S; Fraser C; Sykes M; Sachs DH; LeGuern C
    Transplant Proc; 1995 Feb; 27(1):178-9. PubMed ID: 7878962
    [No Abstract]   [Full Text] [Related]  

  • 5. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of xenogeneic neonatal tolerance to transgenic human leukocyte antigen class I grafts.
    Borenstein SH; Tao KS; Mendicino M; Hu N; West LJ; Chamberlain JW
    Transplantation; 2004 Sep; 78(6):844-52. PubMed ID: 15385803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for selection of unrelated bone marrow donors.
    Martinelli G; Buzzi M; Farabegoli P; Testoni N; Mantovani V; Calori E; Rosti G; Bandini G; Bragliani M; Panzica G
    Bone Marrow Transplant; 1993; 11 Suppl 1():31-2. PubMed ID: 8448542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
    Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells.
    Yang S; Darrow TL; Seigler HF
    Cancer Res; 1997 Apr; 57(8):1561-8. PubMed ID: 9108460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
    Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer using recombinant simian virus 40 viral vectors into mice bone marrow progenitor cells depressed the immunogenicity of keratinocyte stem cells.
    Li W; Xu T; Wang JF; Wu XF; Li M; Lu PY
    Transplant Proc; 2008 Dec; 40(10):3656-9. PubMed ID: 19100460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
    Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
    Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome.
    Kitcharoen K; Witt CS; Romphruk AV; Christiansen FT; Leelayuwat C
    Hum Immunol; 2006 Mar; 67(3):238-46. PubMed ID: 16698448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific xenogeneic (human) tolerance in immunosuppressed mice by combined donor-derived human transferrin and antigens.
    Pierpaoli W; Lesnikov VA; Lesnikova MP; Arrighi S; Bardotti A
    Transplant Proc; 1996 Apr; 28(2):711-2. PubMed ID: 8623359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.